Reference only — not a dosing recommendation.
Product-, indication-, and jurisdiction-specific — see the monograph
- Product: Lutrepulse (gonadorelin acetate) 3.2 mg/vial lyophilised
- Route: Subcutaneous or intravenous via programmable pump
- Dosing: 5 µg every 90 minutes
- Response: Usually within 2-3 weeks
- Continue for 2 weeks after ovulation to support corpus luteum
Studied in trials — not a recommended dose
- 1-20 µg per pulse, various intervals studied.
- Veterinary (Factrel): 100-200 µg IM in cattle for cystic ovaries / FTAI.
- No established or recommended human dose for any indication other than ovulation induction in primary hypothalamic amenorrhea.
Gonadorelin — section dose et administration de la monographie